After the close, Relypsa (RLYP) reported the June 2016 prescriptions for Veltassa. The biotech reported the following numbers for June with the associated growth rate from May:
New patients - free starter: 1,531, up 11%
Outpatient prescriptions: 1,723, up 40%
Hospital: 392, up 42%
The numbers confirm that pent up demand exists for a solution to...